Jiayan Wu

1.6k total citations · 2 hit papers
33 papers, 1.3k citations indexed

About

Jiayan Wu is a scholar working on Biomedical Engineering, Molecular Biology and Immunology. According to data from OpenAlex, Jiayan Wu has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Biomedical Engineering, 16 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Jiayan Wu's work include Nanoplatforms for cancer theranostics (20 papers), RNA Interference and Gene Delivery (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Jiayan Wu is often cited by papers focused on Nanoplatforms for cancer theranostics (20 papers), RNA Interference and Gene Delivery (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Jiayan Wu collaborates with scholars based in China, Singapore and United States. Jiayan Wu's co-authors include Huayu Tian, Jie Chen, Xuesi Chen, Yuanji Feng, Caina Xu, Kanyi Pu, Zhaopei Guo, Lin Lın, Huapan Fang and Lin Lin and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Jiayan Wu

31 papers receiving 1.3k citations

Hit Papers

Biomineralized Two‐Enzyme Nanoparticles Regulate Tumor Gl... 2022 2026 2023 2024 2022 2025 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Biomineralized Two‐Enzyme Nanoparticles Regulate Tumor Glycometabolism Inducing Tumor Cell Pyroptosis and Robust Antitumor Immunotherapy
    2022 157 citations Yuanji Feng, Jiayan Wu et al. Advanced Materials profile →
  2. Hypoxia-tolerant polymeric photosensitizer prodrug for cancer photo-immunotherapy
    2025 19 citations Jie Yu, Jiayan Wu et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiayan Wu China 20 698 563 313 298 225 33 1.3k
Zhanwei Zhou China 20 716 1.0× 542 1.0× 239 0.8× 373 1.3× 228 1.0× 52 1.3k
Cuixia Zheng China 23 947 1.4× 514 0.9× 247 0.8× 482 1.6× 287 1.3× 48 1.6k
João Conniot Portugal 15 588 0.8× 697 1.2× 425 1.4× 451 1.5× 237 1.1× 19 1.6k
Sara Musetti United States 12 821 1.2× 599 1.1× 547 1.7× 526 1.8× 187 0.8× 15 1.6k
Kuo‐Ching Mei United States 18 490 0.7× 438 0.8× 281 0.9× 331 1.1× 185 0.8× 32 1.1k
Chunxiong Zheng China 20 464 0.7× 667 1.2× 203 0.6× 321 1.1× 195 0.9× 34 1.3k
Jianqin Wan China 20 712 1.0× 550 1.0× 164 0.5× 649 2.2× 209 0.9× 32 1.4k
DaeYong Lee South Korea 19 481 0.7× 443 0.8× 255 0.8× 245 0.8× 182 0.8× 33 1.0k
Mian Yu China 16 690 1.0× 503 0.9× 288 0.9× 212 0.7× 323 1.4× 22 1.2k
Qingle Song China 15 910 1.3× 579 1.0× 532 1.7× 486 1.6× 145 0.6× 26 1.4k

Countries citing papers authored by Jiayan Wu

Since Specialization
Citations

This map shows the geographic impact of Jiayan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayan Wu more than expected).

Fields of papers citing papers by Jiayan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayan Wu. The network helps show where Jiayan Wu may publish in the future.

Co-authorship network of co-authors of Jiayan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayan Wu. A scholar is included among the top collaborators of Jiayan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayan Wu. Jiayan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Jie, Jiayan Wu, Jingsheng Huang, et al.. (2025). Hypoxia-tolerant polymeric photosensitizer prodrug for cancer photo-immunotherapy. Nature Communications. 16(1). 153–153. 19 indexed citations breakdown →
2.
Li, Dong‐Hao, et al.. (2025). Shortwave Infrared Hemicyanine-6 for Cancer-Activated and Shaving-Free Preclinical Imaging of Lung Metastasis. Journal of the American Chemical Society. 147(34). 30794–30802.
3.
4.
5.
Huang, Jingsheng, Jing Huang, Jiayan Wu, et al.. (2024). Near‐Infrared Chemiluminophore Switches Photodynamic Processes via Protein Complexation for Biomarker‐Activatable Cancer Therapy. Angewandte Chemie International Edition. 64(12). e202421962–e202421962. 10 indexed citations
6.
Xu, Mengke, Yuxuan Hu, Jiayan Wu, Jing Liu, & Kanyi Pu. (2024). Sonodynamic Nano-LYTACs Reverse Tumor Immunosuppressive Microenvironment for Cancer Immunotherapy. Journal of the American Chemical Society. 146(50). 34669–34680. 33 indexed citations
7.
Wu, Jiayan, et al.. (2024). Exosome‐Inhibiting Polymeric Sonosensitizer for Tumor‐Specific Sonodynamic Immunotherapy. Advanced Materials. 36(25). e2400762–e2400762. 42 indexed citations
8.
Qi, Peng, Ziming Wang, Tongyue Zhang, et al.. (2024). Recent advances in living cell nucleic acid probes based on nanomaterials for early cancer diagnosis. Asian Journal of Pharmaceutical Sciences. 19(3). 100910–100910. 9 indexed citations
9.
Huang, Jingsheng, Mengke Xu, Penghui Cheng, et al.. (2024). A Tandem‐Locked Chemiluminescent Probe for Imaging of Tumor‐Associated Macrophage Polarization. Angewandte Chemie International Edition. 63(21). e202319780–e202319780. 25 indexed citations
10.
Meng, Meng, Jiayan Wu, Yuanji Feng, et al.. (2024). A Comprehensive Strategy Based on High Clinical Translational Nanosystem for Programmable Immunotherapy of Triple Negative Breast Cancer. Advanced Materials. 36(27). e2314309–e2314309. 31 indexed citations
11.
Wu, Jiayan, Yuanji Feng, Zhiyu Yang, et al.. (2023). Gemini nanoparticles-based quadruple therapy (GNQT) achieved effective tumor immunotherapy by comprehensive regulation of tumor microenvironment. Nano Today. 51. 101915–101915. 6 indexed citations
12.
Wu, Jiayan & Kanyi Pu. (2023). Leveraging Semiconducting Polymer Nanoparticles for Combination Cancer Immunotherapy. Advanced Materials. 36(1). e2308924–e2308924. 60 indexed citations
13.
14.
Wu, Jiayan, Yuanji Feng, Tong Li, et al.. (2022). CD47KO/CRT dual-bioengineered cell membrane-coated nanovaccine combined with anti-PD-L1 antibody for boosting tumor immunotherapy. Bioactive Materials. 22. 211–224. 30 indexed citations
15.
Chen, Jie, Huapan Fang, Yingying Hu, et al.. (2021). Combining mannose receptor mediated nanovaccines and gene regulated PD-L1 blockade for boosting cancer immunotherapy. Bioactive Materials. 7. 167–180. 70 indexed citations
16.
Ni, Weidong, Jiayan Wu, Huapan Fang, et al.. (2021). Photothermal-Chemotherapy Enhancing Tumor Immunotherapy by Multifunctional Metal–Organic Framework Based Drug Delivery System. Nano Letters. 21(18). 7796–7805. 91 indexed citations
17.
Wu, Jiayan, Jie Chen, Yuanji Feng, et al.. (2020). An immune cocktail therapy to realize multiple boosting of the cancer-immunity cycle by combination of drug/gene delivery nanoparticles. Science Advances. 6(40). 109 indexed citations
18.
Wu, Jiayan, Jie Chen, Yuanji Feng, Huayu Tian, & Xuesi Chen. (2019). Tumor microenvironment as the “regulator” and “target” for gene therapy. The Journal of Gene Medicine. 21(7). e3088–e3088. 42 indexed citations
19.
Xu, Caina, Zhaopei Guo, Jie Chen, et al.. (2018). Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy. Journal of Controlled Release. 295. 153–163. 91 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhanwei Zhou Breakdown of academic impact, for papers by Cuixia Zheng Breakdown of academic impact, for papers by João Conniot Breakdown of academic impact, for papers by Sara Musetti Breakdown of academic impact, for papers by Kuo‐Ching Mei Breakdown of academic impact, for papers by Chunxiong Zheng Breakdown of academic impact, for papers by Jianqin Wan Breakdown of academic impact, for papers by DaeYong Lee Breakdown of academic impact, for papers by Mian Yu Breakdown of academic impact, for papers by Qingle Song
Rankless by CCL
2026